These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17893257)

  • 1. Effect of exercise training on plasma visfatin and eotaxin levels.
    Choi KM; Kim JH; Cho GJ; Baik SH; Park HS; Kim SM
    Eur J Endocrinol; 2007 Oct; 157(4):437-42. PubMed ID: 17893257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic exercise training-induced decrease in plasma visfatin and insulin resistance in obese female adolescents.
    Lee KJ; Shin YA; Lee KY; Jun TW; Song W
    Int J Sport Nutr Exerc Metab; 2010 Aug; 20(4):275-81. PubMed ID: 20739715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
    Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visfatin in juvenile obesity - the effect of obesity intervention and sex.
    Krzystek-Korpacka M; Patryn E; Bednarz-Misa I; Hotowy K; Noczynska A
    Eur J Clin Invest; 2011 Dec; 41(12):1284-91. PubMed ID: 21569027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome.
    Filippatos TD; Derdemezis CS; Kiortsis DN; Tselepis AD; Elisaf MS
    J Endocrinol Invest; 2007 Apr; 30(4):323-6. PubMed ID: 17556870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding.
    Haider DG; Schindler K; Schaller G; Prager G; Wolzt M; Ludvik B
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1578-81. PubMed ID: 16449335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of simvastatin treatment on plasma visfatin levels in obese women.
    Petreanu M; Eleuterio N; Bosco AA; Sandrim VC
    Gynecol Endocrinol; 2014 Aug; 30(8):577-80. PubMed ID: 24819315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise training lowers plasma visfatin concentrations in patients with type 1 diabetes.
    Haider DG; Pleiner J; Francesconi M; Wiesinger GF; Müller M; Wolzt M
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4702-4. PubMed ID: 16895956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
    Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
    Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
    Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased visfatin after exercise training correlates with improved glucose tolerance.
    Haus JM; Solomon TP; Marchetti CM; O'Leary VB; Brooks LM; Gonzalez F; Kirwan JP
    Med Sci Sports Exerc; 2009 Jun; 41(6):1255-60. PubMed ID: 19461540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visfatin expression in subcutaneous adipose tissue of pre-menopausal women: relation to hormones and weight reduction.
    Kovacikova M; Vitkova M; Klimcakova E; Polak J; Hejnova J; Bajzova M; Kovacova Z; Viguerie N; Langin D; Stich V
    Eur J Clin Invest; 2008 Jul; 38(7):516-22. PubMed ID: 18578692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
    Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
    Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
    de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
    Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.